GetSeriousOK
1時間前
When BIEL's 2026 annual financial statement reveals that Electrome only bought 25,000 units and is lying about having 100,000 units in stock, how will that make you feel about Electrome?
Electrome has a lot of little lies on their website, like their fake testimonials, the AI app that doesn't exist, and now their 100,000 inventory. They seem unethical to me. And they're in the health care business. Huh.
BIEL
Tantalos
10時間前
Well, Electrome did what they said they were going to do.
Over a week ago I placed an order to purchase an ActiPatch. I received an email from them stating that my order will be available for sale starting July 9th.and to order it then.
Today is the 9th and I placed the order, it was processed and I will receive it in a few days.
This morning I placed a buy order for $500.00
1,666,666 shares @ .0003, (2) orders executed @ .0003 for 36,000 and 214,000 shares showing as a buy.
I waited a while and changed my buy order to .0004, (2) orders executed @.00034 for 1,237,175
and 152,500 shares “BUT” shares did not show it as a executed buy!!!!
See, I do my own due diligence getting it straight from the horses mouth. I’ll spend a little on my bets to cover my investments!!
GLTA
art2426
11時間前
Who is artie? ------ Oh I forgot, since you post (pump) here everyday, you must think you 'know' everything. But the real question is ---- do you 'know' how to read and understand financial statements. If you do, you would be embarrassed to pump this everyday here as you do. If you do not understand basic accounting, ask any high school student taking a bookkeeping class and I am sure that they will tell you how horrible they ARE. You see, the financial statements are the most important information one can study for investing in a publicly traded corporation. Even one that is 'family' run ' with no employees, like this one. Yes, especially one like THIS that has lost a key executive that joined another company, along with its only salesperson. Yes, that key executive that the pumpers say left this cash strapped never profitable company, to HELP this family run company. Remember that? How long ago was that? I guess that he was not 'helping' much, as the sales, as shown in those 2025 financials, have been declining the last couple years. --------- OH WELL.
GetSeriousOK
18時間前
Where is the StartEngine crowdfunding campaign?
I think Electrome needs $3 million in Q3 to keep their tour bus on the road. I was thinking they'd get maybe $300,000 on StartEngine with Mayer pitching on the mound, but with Mayer gone, I think they'll be lucky to get $100,000.
I wonder if Electrome gave Crawford and Timothy their money back.
I wonder if we're even going to hear from Electrome again, and if so, will they keep trying to peddle ActiPatches? Regardless, the good news is that Kelly got a couple hundred thousand $$$ from them before they crashed and burned.
The ActiPatch reseller model was all Mayer's idea. Maybe he'll duct-tape that model back together and pitch it elsewhere. I've always wondered whether some entity with ambition and charisma and resources could market and sell the ActiPatch and make some money. Mayer has the first two -- he's only lacking resources.
BIEL
beacham
19時間前
In terms of impact on a whole range of demographics, Redemption stories are pure gold. TW would be at the top of the advertising food chain for that narrative, hands down. Yea, you're right about everything you said, especially the layers of isolation and protection. It's a longshot, for sure. However, TW already can afford anything and everything, medically speaking, and yet the chronic pain and drug abuse has continued unabated for years; possibly still going on despite the most recent mishap.
The Electrome/BIEL Strategic Partnership is expanding rapidly now that the digital infrastructure has been designed, developed, and is being deployed ASAP. The evolution of the program will always be flexible and adaptable. Patient outcomes are a closely monitored metric in the health industry, especially for reimbursement policy. The politics is dirty, I know, but even besides that there is a pathway to contact; a secret tunnel to bypass the protective layers. The man himself, Tiger Woods.
What is he willing to try to reduce his pain and everyday discomfort w/o any of the deleterious side effects? How badly does he, himself, want to get better and 'raise his game' for his pain management and/or elimination? As word of PEMF spreads, the information, the efficacy, NO side effects, portability, etc. more medical personnel are becoming educated about it; the greater the possibility of someone w/ in 'TW's circle' to offer up the possibility. The hurdle is getting him to try it. The payoff is 'off the charts'.
It seems the Electrome political connections are widespread and influential. His doctors, no doubt, are pushing for the more profitable alternatives. Insurance also plays a big role in this potential saga. Insurance is a very important component of Tiger's life; personal, professional, you name it. It's possible they. insurance companies might start getting a little weary of insuring a guy who has an uncanny knack of crashing cars while intoxicated on some weird medical cocktail. Insurance companies don't like making payouts on claims, esp'ly on a regular basis involving a single client.
If you don't dream it, you won't consider it; you won't think about it, won't suggest it, and so it goes away. On the other hand, let's consider it. Tiger Woods has a problem. We have something to offer Tiger Woods. We offer a viable and eminently ‘doable’ alternative. Problem meets Solution. Tiger likes Solution. Solutions wins. We win, BIG !!
“Sic parvis magna” - GREATNESS from small beginnings
All the best, WBeacham
3331
21時間前
BIEL becomes the story stock for 2026 @ PPS = .003 and the GOAT @ PPS =. 10!
A move to .003 represents a 3,000% gain from .0001 — outperforming the 10-year ROI for Apple, Amazon, Netflix, Microsoft, Google, etc.
When this breakout hits, BIEL/Electrome will receive millions of dollars in free publicity, igniting global awareness and accelerating sales and big money will be chasing the stock
BIEL = GOAT @ PPS = .10!
BIEL hitting PPS .10 puts it in the conversation for the greatest stock ever - more than 100,000% appreciation from their all-time low.
Two companies currently compete for the absolute top spot in modern history: Apple and former penny stock Monster Beverage, with each taking about 30 years to get there. Netflix, Nvidia, Microsoft and Amazon only make the honorable mention list.
$250K IS THE MAGIC NUMBER!
$250,000 profit will get the PPS to COPPER @ P/E = 1,000 (not unusual for stocks turning profitable for the first time and with increasing future growth/revenue/profit projections). This will happen when investors become confident the profit will be achieved - likely long before financials are reported (depending on news). Each additional $250K profit increment should equal an additional .01 PPS:
$250K profit = .01 PPS
$1M profit = .04 PPS
$2M profit = .08 PPS
$2.5M profit = .10 PPS in a year or two makes it the greatest stock in history!
The $500K (2025) revenue base and the $41M tax-loss carryforward accelerates profitability.
Pathway to the PPS Milestones is Highly Compressed
The recent validation from the June 30, 2026, Chairman’s Update confirms that the strategic distribution partnership with Electrome Corporation has officially moved forward, satisfying initial conditions and executing the first purchase orders.
Combined with the company reporting a "small profit for calendar year 2025," aggressive cost reduction (office relocation and staff downsizing), the breakout that will occur @ PPS .003 and a $41M tax-loss carryforward, the financial pathway to the PPS milestones is highly compressed.
Timeline for how BIEL could scale to meet these profit milestones based on the Electrome commercial rollout.
The BIEL / Electrome Milestone Timeline
Phase 1: The Magic Number ($250K Profit) = $0.01 PPS
Target Window: Q3 – Q4 2026
Catalyst: Electrome’s official commercial launch and fulfillment of initial purchase orders.
Investor Psychology: As noted, investors will price this in before the 10-K or 10-Q reports. When Electrome provides public metrics or press releases regarding early consumer adoption and platform integration, speculative volume will flood the ~24.7B shares outstanding.
The Math: Achieving $250K in profit requires very minimal revenue overhead now that BIEL is a lean, 4-employee operation with strict cost controls. A P/E of 1,000 on $250K net income supports a market cap of $250M, lifting the current fraction-of-a-cent price ($0.0003) straight into "copper" ($0.01).
Phase 2: Scaling Up ($1M Profit) = $0.04 PPS
Target Window: H1 2027
Catalyst: Consistent, re-occurring purchase orders from Electrome alongside existing channels (Taiwan, veterinary, etc.).
The Acceleration: The $41M tax-loss carryforward acts as a shield, ensuring that every dollar of operational revenue over expenses goes straight to the bottom line without federal tax erosion. Reaching $1M in profit requires roughly $2M–$2.5M in gross revenue, which is well within reach as Electrome scales manufacturing.
Phase 3: The Inflection Point ($2M Profit) $0.08 PPS
Target Window: Late 2027
Catalyst: Expanded clinical adoption of Pulsed Shortwave Therapy (PSWT) in surgical/postoperative settings and international distribution traction.
Market Dynamics: At $2M in pure profit, BIEL transitions from an OTC micro-cap story into a fundamentally sound, high-growth medical device play.
Phase 4: History in the Making ($2.5M Profit) = $0.10 PPS
Target Window: Mid-2028 (Within the "year or two" window)
Catalyst: Total market penetration via Electrome's commercial platform and mature multi-channel revenue.
The Result: A $0.10 PPS translates to a market capitalization of roughly $2.47 Billion. With zero tax liabilities on the horizon due to the carryforward, an explosive margins profile makes this milestone entirely achievable if Electrome can effectively capture a slice of the multi-billion-dollar non-opioid chronic pain market.
GetSeriousOK
24時間前
You people want Tiger Woods as a spokesman.
He's a criminal. DUI's are crimes, and they are not victimless crimes.
Pity that OJ is dead. You probably wanted him too. Now, on the other hand, we sure have the means and methods to contact BIEL and/ Electrome. But do you have means and methods for getting a RESPONSE? Mayer used to respond to queries, but since his exit, I can't get anything out of Electrome.
Pumping Electrome is worse than counting chickens before they're hatched. It''s counting chickens before you have any eggs.
BIEL
art2426
1日前
>>>Having the chance to own shares of BIEL at $0.0004<<< --- You had a chance to buy at .0001. Yes it traded at ROCK BOTTOM, LOL!
>>> I ‘Believe & Trust’ CEO Kelly will make the best decision given the circumstances. All things considered, we are where we are b/c of CEO Kelly Whelan.<<< --- You ' believe and trust' a CEO that said SYNERGY will be selling their products, and only admitted 2 years later the there was no deal with SYNERGY? The same CEO that said they had a deal with MUNDIPHARMA and again -- never happened. How about when that CEO said that 2024 will be the year for BIolecteonics? How did THAT work out?
>>>Letting this slip away w/o taking advantage will be a lifelong regret that’ll eat you up from the inside out for years to come.<<< --- LOL! Staying invested in this company while never showing a profit like this has for over 20 years and thus resulting in the inevitable conclusion, will be "be a lifelong regret and eat you up from the inside out" for years" to come.
But one thing you ARE correct about --- >>>"All things considered, we are where we are b/c of CEO Kelly Whelan."<<< --- Yes you ARE! .0002/.0003 stock price.
DayTimeLantern
1日前
Greeting, WB! Great post by-the-bye! But regarding contacting Mr. Woods as you suggested, we don't need to consider any of his contact points. It would be an exercise in futility anyway, for I'm sure his contact screening is layered up to yingyang. No Doubts! Now, on the other hand, we sure have the means and methods to contact BIEL and/ Electrome. Maybe someone should put a bug in their ear regarding the recruitment of Mr. Woods. Of course, his going prices would be in the category of a Moon-Shot. But who knows, gaining a better quality of life, he might be gettable. Also, offer him a resonable amount of cash, plus a hefty block of stock option(s), etc., that might do it. Just A Thought!
GLTA, Go BIEL!!
beacham
1日前
Coordination & Timing (C&T); Belief & Trust (B&T) … the sweet spot …
Opportunity is a funny thing. How often does it pass by right in front of you, only to realize it in hindsight 15 years later? Or not appreciate a really good situation when you are neck deep in it only to let it slip away? We have all been there. Having the chance to own shares of BIEL at $0.0004, let’s say, is one of these times. Revenue is coming in right now, deals are being finalized, markets are expanding. Letting this slip away w/o taking advantage will be a lifelong regret that’ll eat you up from the inside out for years to come.
There has been some ‘back & forth’ on how one goes about ‘writing off’ or ‘Accounting for’ debt as per the required disclosure regulations. I’m not going to get into the ‘weeds’ in figuring out the minutiae of re-structuring debt. That something CAN be done w/ minimal disruption, and strong upside for the bottom line, is plenty good enough for me. And this is where Belief & Trust comes in. I ‘Believe & Trust’ CEO Kelly will make the best decision given the circumstances. All things considered, we are where we are b/c of CEO Kelly Whelan. I anticipate an emerging and significantly profitable future on the horizon.
Our CEO has been through the wringer at least twice w/ KT Tape and Synergy. I still believe both parties went into the agreement w/ ‘less-than-honorable’ (potentially malicious) intentions. She, and BIEL, survived, a little beat up but wiser for the experience. She went into negotiations w/ Electrome w/ eyes wide open and renewed determination. We have over 6 months before the next earnings are reported. A lot can happen between now and then. The recent update from COB Staelin is the opening salvo, imo. And this is where Coordination & Timing comes into play. It’ll come …
Tiger Woods is fast becoming, if not already, the poster child for addiction to prescription pain medication. After multiple (4?) DUI car accidents he should be in rehab now. His back injury from years ago has nothing to do w/ golf. He hurt it trying to emulate his Dad who was special forces in Vietnam. He tried learning some of that stuff and hurt his back in the process. He’s got all the money he needs to get whatever is possibly available via Allopathic medicine. His ‘team’ should know better, truth be told, and Mr. Woods needs to face some harsh reality. Maybe he should try something different. Like PEMF RecoveryRx, for example, connected to some Electrome AI wizardry. Getting him better and feeling much healthier would be an all-time celebrity coup in terms of exposure. I am proposing contacting Tiger Woods to become a spokesman for Electrome/BIEL Strategic Partnership. Anyone have his number?
FOMO - The Biellionaire says 250k in profit is the magic # to take us to a pps of $0.01. I think we are already there. We have confirmed the order to Taiwan and manufacturing is taking place for Electrome’s 1st order. And where is that going? Houston VA or 3,700 pharmacies or both? Once you understand the opportunity buying shares can’t be done fast enough. The general population of retail investors has not yet got onboard, for whatever reason, but when they do, this thing could fly leaving $0.01 in the dust.
Still waters run deep. There are NO coincidences.
Is still listed on OTC as “Pink Limited Market” even though BIEL has met all the requirements. Baffling. Coordination & Timing ???
“Sic parvis magna” - GREATNESS from small beginnings
All the best, WBeacham
3331
2日前
Pathway to the PPS Milestones is Highly Compressed
The recent validation from the June 30, 2026, Chairman’s Update confirms that the strategic distribution partnership with Electrome Corporation has officially moved forward, satisfying initial conditions and executing the first purchase orders.
Combined with the company reporting a "small profit for calendar year 2025," aggressive cost reduction (office relocation and staff downsizing), and a $41M tax-loss carryforward, the financial pathway to the PPS milestones is highly compressed.
Timeline for how BIEL could scale to meet these profit milestones based on the Electrome commercial rollout.
The BIEL / Electrome Milestone Timeline
Phase 1: The Magic Number ($250K Profit) = $0.01 PPS
Target Window: Q3 – Q4 2026
Catalyst: Electrome’s official commercial launch and fulfillment of initial purchase orders.
Investor Psychology: As noted, investors will price this in before the 10-K or 10-Q reports. When Electrome provides public metrics or press releases regarding early consumer adoption and platform integration, speculative volume will flood the ~24.7B shares outstanding.
The Math: Achieving $250K in profit requires very minimal revenue overhead now that BIEL is a lean, 4-employee operation with strict cost controls. A P/E of 1,000 on $250K net income supports a market cap of $250M, lifting the current fraction-of-a-cent price ($0.0003) straight into "copper" ($0.01).
Phase 2: Scaling Up ($1M Profit) = $0.04 PPS
Target Window: H1 2027
Catalyst: Consistent, re-occurring purchase orders from Electrome alongside existing channels (Taiwan, veterinary, etc.).
The Acceleration: The $41M tax-loss carryforward acts as a shield, ensuring that every dollar of operational revenue over expenses goes straight to the bottom line without federal tax erosion. Reaching $1M in profit requires roughly $2M–$2.5M in gross revenue, which is well within reach as Electrome scales manufacturing.
Phase 3: The Inflection Point ($2M Profit) $0.08 PPS
Target Window: Late 2027
Catalyst: Expanded clinical adoption of Pulsed Shortwave Therapy (PSWT) in surgical/postoperative settings and international distribution traction.
Market Dynamics: At $2M in pure profit, BIEL transitions from an OTC micro-cap story into a fundamentally sound, high-growth medical device play.
Phase 4: History in the Making ($2.5M Profit) = $0.10 PPS
Target Window: Mid-2028 (Within the "year or two" window)
Catalyst: Total market penetration via Electrome's commercial platform and mature multi-channel revenue.
The Result: A $0.10 PPS translates to a market capitalization of roughly $2.47 Billion. With zero tax liabilities on the horizon due to the carryforward, an explosive margins profile makes this milestone entirely achievable if Electrome can effectively capture a slice of the multi-billion-dollar non-opioid chronic pain market.
art2426
3日前
>>>I'm surprised we are in the 2,s with this flop we should be sitting at .0001<<<
I agree and so am I surprised. When you see that they have $13,093,535 in note/loans that have all come DUE but remain UNPAID and have losses totaling $41,277,336, now with decreasing sales, this surely deserves the bottom of possible stock prices.
3331
3日前
Simple Math: BIEL = GOAT!
BIEL hitting PPS .10 puts it in the conversation for the greatest stock ever - more than 100,000% appreciation from their all-time low.
Two companies currently compete for the absolute top spot in modern history: Apple and former penny stock Monster Beverage, with each taking about 30 years to get there. Netflix, Nvidia, Microsoft and Amazon only make the honorable mention list.
$250K IS THE MAGIC NUMBER!
$250,000 profit will get the PPS to COPPER @ P/E = 1,000 (not unusual for stocks turning profitable for the first time and with increasing future growth/revenue/profit projections). This will happen when investors become confident the profit will be achieved - likely long before financials are reported (depending on news). Each additional $250K profit increment should equal an additional .01 PPS:
$250K profit = .01 PPS
$1M profit = .04 PPS
$2M profit = .08 PPS
$2.5M profit = .10 PPS in a year or two makes it the greatest stock in history!
The $500K (2025) revenue base and the $41M tax-loss carryforward accelerates profitability.
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
toohot
1日前
Gailm
2日前
メールアドレスで登録
